Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement

Saved in:
Bibliographic Details
Published inLeukemia & lymphoma Vol. 61; no. 12; pp. 2980 - 2984
Main Authors Furqan, Fateeha, Watson, Grace, Samaniego, Felipe, Fayad, Luis E., Morrison, Michael W., Thompson, Philip A., Steiner, Raphael E., Chi, Linda, Dabaja, Bouthaina, Pinnix, Chelsea C., Neelapu, Sattva S., Nastoupil, Loretta J., Strati, Paolo
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 14.10.2020
Subjects
Adenine - analogs & derivatives
Central Nervous System
Humans
Lymphoma, B-Cell, Marginal Zone - diagnosis
Lymphoma, B-Cell, Marginal Zone - drug therapy
Piperidines
Pyrazoles - adverse effects
Pyrimidines - adverse effects
Online AccessGet full text

Cover

Author Thompson, Philip A.
Dabaja, Bouthaina
Steiner, Raphael E.
Furqan, Fateeha
Pinnix, Chelsea C.
Strati, Paolo
Samaniego, Felipe
Watson, Grace
Nastoupil, Loretta J.
Neelapu, Sattva S.
Chi, Linda
Fayad, Luis E.
Morrison, Michael W.
AuthorAffiliation 1 Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4 Department of Neuro-Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
3 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
2 Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
AuthorAffiliation_xml – name: 5 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
– name: 4 Department of Neuro-Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
– name: 2 Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
– name: 1 Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
– name: 3 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Author_xml – sequence: 1
  givenname: Fateeha
  surname: Furqan
  fullname: Furqan, Fateeha
  organization: Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
– sequence: 2
  givenname: Grace
  surname: Watson
  fullname: Watson, Grace
  organization: Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
– sequence: 3
  givenname: Felipe
  surname: Samaniego
  fullname: Samaniego, Felipe
  organization: Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
– sequence: 4
  givenname: Luis E.
  surname: Fayad
  fullname: Fayad, Luis E.
  organization: Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
– sequence: 5
  givenname: Rashmi Kanagal-Shamanna
  orcidid: 0000-0001-7829-5249
  organization: Department of Hematopathology, The University of Texas MD Anderson Cancer Center
– sequence: 6
  givenname: Michael W.
  surname: Morrison
  fullname: Morrison, Michael W.
  organization: Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
– sequence: 7
  givenname: Philip A.
  surname: Thompson
  fullname: Thompson, Philip A.
  organization: Department of Leukemia, The University of Texas MD Anderson Cancer Center
– sequence: 8
  givenname: Raphael E.
  orcidid: 0000-0003-3717-3629
  surname: Steiner
  fullname: Steiner, Raphael E.
  organization: Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
– sequence: 9
  givenname: Linda
  surname: Chi
  fullname: Chi, Linda
  organization: Department of Neuro-Radiology, The University of Texas MD Anderson Cancer Center
– sequence: 10
  givenname: Bouthaina
  surname: Dabaja
  fullname: Dabaja, Bouthaina
  organization: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center
– sequence: 11
  givenname: Chelsea C.
  orcidid: 0000-0003-3982-3664
  surname: Pinnix
  fullname: Pinnix, Chelsea C.
  organization: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center
– sequence: 12
  givenname: Sattva S.
  surname: Neelapu
  fullname: Neelapu, Sattva S.
  organization: Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
– sequence: 13
  givenname: Loretta J.
  surname: Nastoupil
  fullname: Nastoupil, Loretta J.
  organization: Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
– sequence: 14
  givenname: Paolo
  surname: Strati
  fullname: Strati, Paolo
  organization: Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32650677$$D View this record in MEDLINE/PubMed
BookMark eNp9kEtr3DAUhUVJ6OTRn5CiP-BUL8v2piSEPgYCXSR7cW1LYzW2NEiaCc6vr8xMhnbTlS465557-C7RmfNOI3RDyS0lNflCiWA1bcQtIyx_VQ2tRfMBXVDCmoIJws-WWbBiMa3QZYy_CSFlI9lHtOJMlkRW1QV6Wbdhl6yzbdFC1D1Ogw6wnbHxYZlxChrSpF3C3uAJwsY6GPFbLoPHedoOfgL8atOAu-wJWXI67P0u4jjHpCds3d6Pe70kXKNzA2PUn47vFXr6_u354Wfx-OvH-uH-seiErFNBS9GDbHgHQnagGRN11xJeAdXS9KxmfW2ElsIsChAjuZRAGl1ykJrxK_T1kLrdtZPuj7XUNtjcflYerPpXcXZQG79Xlaw5lzQHlIeALvgYgzanXUrUwl69s1cLe3Vkn_c-_334tPUOOxvuDgbrMt0JXn0Ye5VgHn0wAVxno-L_v_EHm2iZVQ
CitedBy_id crossref_primary_10_1111_bjh_19238
crossref_primary_10_5045_br_2021_2020322
crossref_primary_10_1080_14656566_2021_1941864
Cites_doi 10.1186/s12885-018-4632-y
10.1182/blood-2016-02-697193
10.18632/oncotarget.25622
10.1212/01.wnl.0000218284.23872.eb
10.1182/blood-2018-10-879593
10.1080/10428194.2016.1218006
10.1182/blood-2015-05-647834
10.1007/s00277-010-0976-3
10.1200/JCO.1997.15.3.1110
10.1182/blood-2016-01-643569
10.1200/JCO.2017.35.15_suppl.e13083
10.1016/j.clml.2017.09.012
10.1182/blood-2016-10-747345
10.1016/j.ccell.2017.04.012
10.1200/JCO.2013.54.8800
10.1002/cam4.2732
ContentType Journal Article
Copyright 2020 Informa UK Limited, trading as Taylor & Francis Group 2020
Copyright_xml – notice: 2020 Informa UK Limited, trading as Taylor & Francis Group 2020
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOI 10.1080/10428194.2020.1791849
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1029-2403
EndPage 2984
ExternalDocumentID 10_1080_10428194_2020_1791849
32650677
1791849
Genre Letters to the Editor
Letter
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: P30 CA016672
GroupedDBID ---
00X
03L
0BK
0R~
29L
36B
4.4
53G
5GY
AAJNR
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABDBF
ABEIZ
ABLKL
ABPTK
ABUPF
ACENM
ACFUF
ACGEJ
ACGFS
ACLSK
ADCVX
ADFCX
ADRBQ
ADXPE
AECIN
AENEX
AEOZL
AEXWM
AEYQI
AFKVX
AFWLO
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJWEG
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMDAE
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
DU5
EAP
EBB
EBC
EBD
EBS
EBX
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
J.N
KRBQP
KSSTO
KWAYT
KYCEM
LGLTD
LJTGL
M4Z
O9-
P2P
RNANH
RVRKI
SV3
TFDNU
TFL
TFW
TUS
UEQFS
V1S
~1N
5VS
AALIY
AAORF
ABLIJ
ABWCV
ABXYU
ABZEW
ACIEZ
ACKZS
ADFOM
ADFZZ
AEIIZ
AFLEI
AJVHN
ALYBC
AWYRJ
BRMBE
CAG
CGR
COF
CUY
CVF
CYYVM
CZDIS
DRXRE
DWTOO
ECM
EIF
EJD
HF~
JENTW
M44
NPM
NUSFT
QQXMO
TBQAZ
TDBHL
TERGH
TUROJ
UDS
Y6R
ZGI
ZXP
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-c468t-154da693ca46cae2248cb037a1e6fd282d8f4e64f2248a0f6366a09e53a6e23
ISSN 1042-8194
IngestDate Tue Sep 17 21:21:17 EDT 2024
Fri Aug 23 02:53:41 EDT 2024
Wed Oct 16 00:43:07 EDT 2024
Tue Jun 13 19:27:13 EDT 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c468t-154da693ca46cae2248cb037a1e6fd282d8f4e64f2248a0f6366a09e53a6e23
Notes Authorship Contributions
FF collected clinical data and wrote the paper; LJN, FS, LEF, PAT, BD, CCP, SSN and RES provided clinical care to patients and coauthored the paper; GW and MWM collected clinical data and coauthored the paper; RKS reviewed pathological findings and coauthored the paper; LC reviewed neuro-radiological findings and coauthored the paper; PS designed the study, collected and analyzed the data, provided clinical care to patients, and wrote the paper.
ORCID 0000-0003-3982-3664
0000-0003-3717-3629
0000-0001-7829-5249
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683361
PMID 32650677
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7683361
crossref_primary_10_1080_10428194_2020_1791849
pubmed_primary_32650677
informaworld_taylorfrancis_310_1080_10428194_2020_1791849
PublicationCentury 2000
PublicationDate 2020-10-14
PublicationDateYYYYMMDD 2020-10-14
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-14
  day: 14
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Leukemia & lymphoma
PublicationTitleAlternate Leuk Lymphoma
PublicationYear 2020
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References CIT0010
CIT0001
CIT0012
CIT0011
CIT0003
CIT0014
CIT0002
CIT0013
CIT0005
CIT0016
CIT0004
CIT0015
CIT0007
CIT0006
CIT0017
CIT0009
CIT0008
References_xml – ident: CIT0017
  doi: 10.1186/s12885-018-4632-y
– ident: CIT0008
  doi: 10.1182/blood-2016-02-697193
– ident: CIT0011
  doi: 10.18632/oncotarget.25622
– ident: CIT0013
  doi: 10.1212/01.wnl.0000218284.23872.eb
– ident: CIT0016
  doi: 10.1182/blood-2018-10-879593
– ident: CIT0005
  doi: 10.1080/10428194.2016.1218006
– ident: CIT0015
  doi: 10.1182/blood-2015-05-647834
– ident: CIT0004
  doi: 10.1007/s00277-010-0976-3
– ident: CIT0009
  doi: 10.1200/JCO.1997.15.3.1110
– ident: CIT0001
  doi: 10.1182/blood-2016-01-643569
– ident: CIT0002
  doi: 10.1200/JCO.2017.35.15_suppl.e13083
– ident: CIT0003
  doi: 10.1016/j.clml.2017.09.012
– ident: CIT0007
– ident: CIT0006
  doi: 10.1182/blood-2016-10-747345
– ident: CIT0014
  doi: 10.1016/j.ccell.2017.04.012
– ident: CIT0010
  doi: 10.1200/JCO.2013.54.8800
– ident: CIT0012
  doi: 10.1002/cam4.2732
SSID ssj0005962
Score 2.3474374
SourceID pubmedcentral
crossref
pubmed
informaworld
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2980
SubjectTerms Adenine - analogs & derivatives
Central Nervous System
Humans
Lymphoma, B-Cell, Marginal Zone - diagnosis
Lymphoma, B-Cell, Marginal Zone - drug therapy
Piperidines
Pyrazoles - adverse effects
Pyrimidines - adverse effects
Title Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement
URI https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1791849
https://www.ncbi.nlm.nih.gov/pubmed/32650677
https://pubmed.ncbi.nlm.nih.gov/PMC7683361
Volume 61
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaWrYS4IN5secgHbquEZJ14nWMLDQUBly5Sb5GTtWnUNltCUqn9I_xdZmLnVVbidYmycTa2PF_GY-ebz4S8WgodZjBMOZnElBxfcEdo7TsqSgOAs-K-Ich-5odfgg_H4fFk8mPAWqqr1M2ut-aV_ItV4RrYFbNk_8Ky3UPhApyDfeEIFobjH9n4fVrC04s8dXAwapiQKBHQUQd7Fjl-RZel2QLregOB5dkVmHFzLi333KzxzgvwHMiJNfrO87wA53XZk2PavGlVn6rzXDawaR_UAaEuv5lF1RjCWHXSu31Z2eyud6Xs8XQkUYFDfW2WbGN1ll90RbG8MgD8WOff5wfucIUCpqNI-OhXKFe_bBYy8LeYHQRBiblb2WuL5qMPGzppo9jegnExdLmR2QrKDt_wM9g6NBguJVaI9bnYUBe1WYWRTL2hum1LbpGdxTIKwynZ2dt_ux_37KGImw_ptv1tcpjwXm-tYhT2jERxB6HPmJY7iHNW98hdO0GhewZt98lEFQ_I7U-WgvGQnN4AHbWgo1AXntMOdHSjaQs6iqCjLVYogo7aBlALOmpARwege0SO4oPVm0PH7tjhZAEXlQPx-FryiGUy4JlUEB6KLPXYUvqK6zXM7tdCB4oHGkukpznjXHqRCpnkasEek2kBrXlKKATpQi088C8oIShUKnW29jOP6RB3lOUz4rbdmVwYWZbEt2q3bf8n2P-J7f8ZiYadnlQNKLXBY8J-898nxjBdVTDnCVF6cUaWI5N1N6Bo-7ikyE8a8XaY3jPG_d3_aM8zcqd_zZ6TaVXW6gWExlX60sL0J_OSuCc
link.rule.ids 230,315,786,790,891,27955,27956
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ibrutinib-based+therapy+for+the+treatment+of+marginal+zone+lymphoma+with+central+nervous+system+involvement&rft.jtitle=Leukemia+%26+lymphoma&rft.au=Furqan%2C+Fateeha&rft.au=Watson%2C+Grace&rft.au=Samaniego%2C+Felipe&rft.au=Fayad%2C+Luis+E.&rft.date=2020-10-14&rft.pub=Taylor+%26+Francis&rft.issn=1042-8194&rft.eissn=1029-2403&rft.volume=61&rft.issue=12&rft.spage=2980&rft.epage=2984&rft_id=info:doi/10.1080%2F10428194.2020.1791849&rft.externalDocID=1791849
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1042-8194&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1042-8194&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1042-8194&client=summon